The following Structured Product Label (SPL) was submitted to the FDA by Dpt Laboratories, Ltd. for the product Scytera (NDC 63094-0801). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding description, active ingredient - purpose, use, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Description
Scytera™ Foam is an emollient foam containing 10% coal tar topical
solution (Liquor Carbonis Detergens) equivalent to 2% coal tar.
Active Ingredient - Purpose
Active
ingredient: Coal Tar 2% (from Coal Tar Topical Solution USP,
10%) Purpose: Psoriasis
Use
For relief of the symptoms of psoriasis.
Warnings
For
external use only. FlammableAvoid fire, flame, or smoking during and immediately following application.
WarningThis product contains chemicals known to the state of California to cause cancer.Patent PendingMade in USA. Marketed by:Promius Pharma, LLC Bridgewater,
NJ 08807 Under license from Foamix LTD, Israel
Do Not Use
- for prolonged periods
without consulting a doctor
- this product in or around
the rectum or in the genital area or groin except on the advice of a doctor
Ask A Doctor Before Use If You Have
A
condition that covers a large area of your body.
Ask A Doctor Or Pharmacist Before Use If You Are
Using
the product with other forms of psoriasis therapy such as ultraviolet radiation
or prescription drugs.
When Using This Product
- avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with
water.
- use caution in exposing skin to sunlight after applying this product. It
may increase your tendency to sunburn for up to 24 hours after application.
- product can stain clothing, contact lenses, and hair. To minimize
staining, allow product to dry before contact.
Stop Use And Ask Doctor If
Condition worsens or does not improve after regular use of this product as directed.
If Pregnant Or Breastfeeding
Ask a health professional before use.
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a poison control center right
away.
Directions
- shake the can well before use.
- invert the can to dispense. Upright dispensing will cause loss of
propellant.
- apply to affected areas one to four times daily or as directed by a doctor.
- contents under pressure. Do not puncture or incinerate.
- store at 68°F to 77°F (20°C to 25°C)
- do not expose to heat or store at temperatures above 120°F (49°C)
Inactive Ingredients
Caprylic/capric triglyceride, ceteareth 20, citric acid, cyclomethicone,
dimethicone, EDTA disodium, glycerin, hydroxypropyl methyl cellulose, isopropyl
myristate, peppermint oil, phenoxyethanol, potassium sorbate, purified water,
sodium citrate, stearic acid, xanthan gum, hydrocarbon (propane/butane)
propellant.
Questions?
1-888-966-8766
Scytera™ (Coal Tar)Foam 2%, 100 G
Carton and Can LabelNDC 67857-801-52Psoriasis FoamScytera™ (Coal Tar) Foam 2%Promius Pharma™NET WT. 3.3 oz (100 g)Carton (California)NDC 67857-801-26Psoriasis FoamScytera™ (Coal Tar) Foam 2%Promius Pharma™NET WT. 3.3 oz (100 g)
Scytera™ (Coal Tar)Foam 2%, 12 G Sample Size
Packer (Box)Available in 100 g CansScytera™
(Coal Tar) Foam 2%Promius Pharma™Professional SamplesNet Quantity 12 x 12 g CansNDC 67857-801-12Packer (Box) (California)Available in 100 g CansScytera™
(Coal Tar) Foam 2%Promius Pharma™Professional SamplesNet Quantity 12 x 12 g CansNDC 67857-801-19Can LabelNDC 67857-801-12
Psoriasis Foam
Scytera™
(Coal Tar) Foam 2%SAMPLE, NOT FOR SALENET WT. 0.4 oz (12 g)
* Please review the disclaimer below.